labwaggoner.bsky.social
Focused on innate immune mechanisms governing pathogenesis of disease and on NK-cell based therapies for disease. Opinions expressed are Dr. Waggoner's alone and not on behalf of lab staff or employer.
👤 Joined on 16 November 2024
Followers
Following
Total Posts
@labwaggoner.bsky.socialCongratulations to Dr. Yale Michaels on receiving a $550,000 Canadian Cancer Society Grant to advance the next generation of CAR T-cell therapy for cancer. His research aims to develop stem cell-based CAR T treatments that could reduce costs, shorten wait times, and make it accessible for patients.
Show PostPublished in The New England Journal of Medicine. Peer-reviewed. Large sample size. Sound methodology. An antiviral pill has, for the FIRST time, been shown to PREVENT COVID-19 in individuals exposed to SARS-CoV-2. Ensitrelvir blocks the enzyme coronaviruses need to make new copies of themselves.
Show PostDengue vaccines face a uniquely difficult challenge: protecting against four distinct viral serotypes at once. 🦟 Our new study in JEM: rupress.org/jem/article/... A 🧵 on why tetravalent vaccine design does not necessarily mean tetravalent immunity.
Show PostCongrats @labwaggoner.bsky.social !
Show Post3D genome mapping in rare ILC3 immune cells linked Crohn’s risk variants to more than 100 genes they may affect. About half had not previously been connected to the disease. doi.org/hcdmrr
Show Post